Article
Uncovering Hereditary Risk: Germline Homologous Recombination Repair Variant Spectrum in a Large North Indian Cancer Cohort (INSIGHT-HRR).
JCO global oncology - 1 Aug 2026
Kapoor Akhil, Uthale Srushti, Chain Anamika, Rungta Archi, Anoop Anjana, Gupta Anuj, Sansar Bipinesh, Mishra Bal Krishna, Pal Ankita, Thakkar Soumya, Sarin Rajiv
Abstract excerpt
PURPOSE: Homologous recombination repair (HRR) pathway defects are critical drivers of hereditary cancers, yet population-specific prevalence data from India remain limited. Current testing practices disproportionately focus on BRCA1/2, potentially underidentifying patients with other HRR gene variants who could benefit from targeted therapies. METHODS: A retrospective observational cohort study was conducted,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
